Riskpilot← Back to searchSign inGet full accessNAMSEN FYSIOTERAPI AS
ASActiveOrg 920721966Navarvegen 5B, 7820 SpillumPhysiotherapy activities · NACE 8695Est. 20182 employees
Revenue 2024
NOK 756K
-18% vs 2023
EBITDA margin
-21.4%
-1043% vs 2023
Equity ratio
132.0%
Financial strength
Net profit 2024
NOK -161K
-2390% vs 2023
| Revenue | NOK 756K | -18% |
| EBITDA | NOK -162K | -1043% |
| Net profit | NOK -161K | -2390% |
| Total assets | NOK -140K | -617% |
| Equity | NOK -184K | -2715% |
| Employees | 2 | — |
Legal name
NAMSEN FYSIOTERAPI AS
Org number
920721966
Legal form
Aksjeselskap
NACE code
8695 · Physiotherapy activities
Founded
12. april 2018
Share capital
NOK 30 000
Employees
2 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Daglig leder alene. Styrets leder alene.
Company purpose
Fysioterapi og fysikalsk oppfølging. Grupper og konsulenttjenester relatert til dette fagområdet.
Address
Navarvegen 5B, 7820 Spillum
Phone
+4745222956
Email
anja@namsen-fysioterapi.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 788 | 848 | 887 | 922 | 756 |
| Staff expenses | −230 | −220 | −237 | −262 | −215 |
| EBITDA | 194 | 155 | 286 | 17 | −162 |
| Depreciation & amort. | −209 | −188 | −169 | −0 | −0 |
| EBIT | −15 | −33 | 117 | 17 | −162 |
| Net financials | −104 | −95 | −115 | 0 | 0 |
| Profit before tax | −119 | −128 | 2 | 18 | −161 |
| Tax | −0 | −0 | −0 | 11 | −0 |
| Net profit | −119 | −128 | 2 | 7 | −161 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | −2 247 | −2 172 | −2 075 | 27 | −140 |
| Equity | 30 | 30 | 30 | 7 | −184 |
| Long-term debt | −2 277 | −2 202 | −2 105 | 0 | 0 |
| Short-term debt | 0 | 0 | 0 | 20 | 45 |
| Total debt | −2 277 | −2 202 | −2 105 | 20 | 45 |
EBITDA margin
-21.4%
This company
15.8%
Market median
-235% vs market
20202024
Equity ratio
-18434100.0%
This company
38.2%
Market median
-48256906% vs market
20202024
Return on equity
-16139000.0%
This company
18.4%
Market median
-87712057% vs market
20202024
Net profit margin
-21.3%
This company
8.1%
Market median
-363% vs market
20202024
Asset turnover
756319.00×
This company
1.12×
Market median
+67528382% vs market
20202024
Debt / equity
0.24×
This company
0.62×
Market median
+61% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2018 | |
| Chairman | 2018 | |
| Board of Directors | 2018 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of NAMSEN FYSIOTERAPI AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Johan Ketil Jørstad | Board of Directors | 0 companies |
| Anja Susanne Høgenhaug | Chairman | 0 companies |
| Yvonne Renate Høgenhaug | Board of Directors | 0 companies |